Regulus Therapeutics
RGLS
#6949
Rank
โ‚น50.75 B
Marketcap
โ‚น733.07
Share price
0.00%
Change (1 day)
469.51%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: โ‚น50.75 Billion

As of December 2025 Regulus Therapeutics has a market cap of โ‚น50.75 Billion. This makes Regulus Therapeutics the world's 6949th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น50.75 B486.52%
2024โ‚น8.65 B301.56%
2023โ‚น2.15 B12.87%
2022โ‚น1.90 B-44.22%
2021โ‚น3.42 B-45.41%
2020โ‚น6.26 B370.01%
2019โ‚น1.33 B132.49%
2018โ‚น0.57 B-91.69%
2017โ‚น6.90 B-14.69%
2016โ‚น8.09 B-73.49%
2015โ‚น30.52 B-38.66%
2014โ‚น49.75 B160.8%
2013โ‚น19.07 B54.35%
2012โ‚น12.35 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
โ‚น8.778 T 17,196.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
โ‚น10.861 T 21,299.92%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น2.389 T 4,607.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น25.119 T 49,392.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
โ‚น5.437 T 10,613.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น14.99 B-70.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น9.537 T 18,691.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น267.50 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA